Actinogen Medical Ltd (ACW)

Currency in AUD
0.042
+0.001(+2.44%)
Delayed Data·
ACW is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0410.042
52 wk Range
0.0190.072
Key Statistics
Bid/Ask
0.041 / 0.042
Prev. Close
0.041
Open
0.042
Day's Range
0.041-0.042
52 wk Range
0.019-0.072
Volume
436.45K
Average Volume (3m)
5.1M
1-Year Change
35.4839%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACW Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.080
Upside
+90.48%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Actinogen Medical Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Actinogen Medical Ltd Company Profile

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Compare ACW to Peers and Sector

Metrics to compare
ACW
Peers
Sector
Relationship
P/E Ratio
−8.2x−5.9x−0.5x
PEG Ratio
0.15−0.080.00
Price/Book
17.5x2.6x2.6x
Price / LTM Sales
19.9x17.3x3.2x
Upside (Analyst Target)
95.1%221.2%51.3%
Fair Value Upside
Unlock2.3%8.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.080
(+90.48% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
1.87M / --
EPS Revisions
Last 90 days

ACW Income Statement

People Also Watch

23.720
ORI
0.00%
15.17
EVN
-3.56%
0.273
AAR
-4.39%
0.190
AGD
-5.00%

FAQ

What Is the Actinogen Medical (ACW) Stock Price Today?

The Actinogen Medical stock price today is 0.042 AUD.

What Stock Exchange Does Actinogen Medical Trade On?

Actinogen Medical is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Actinogen Medical?

The stock symbol for Actinogen Medical is "ACW."

What Is the Actinogen Medical Market Cap?

As of today, Actinogen Medical market cap is 150.180M AUD.

What Is Actinogen Medical's Earnings Per Share (TTM)?

The Actinogen Medical EPS (TTM) is -0.006.

When Is the Next Actinogen Medical Earnings Date?

Actinogen Medical will release its next earnings report on Jun 03, 2026.

From a Technical Analysis Perspective, Is ACW a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Actinogen Medical Stock Split?

Actinogen Medical has split 4 times.

How Many Employees Does Actinogen Medical Have?

Actinogen Medical has 6 employees.

What is the current trading status of Actinogen Medical (ACW)?

As of Mar 05, 2026, Actinogen Medical (ACW) is trading at a price of 0.042 AUD, with a previous close of 0.041 AUD. The stock has fluctuated within a day range of 0.041 AUD to 0.042 AUD, while its 52-week range spans from 0.019 AUD to 0.072 AUD.

What Is Actinogen Medical (ACW) Price Target According to Analysts?

The average 12-month price target for Actinogen Medical is 0.080 AUD, with a high estimate of 0.08 AUD and a low estimate of 0.08 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +90.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.